Detailed price information for Neuroone Medical Technologies Corp (NMTC-Q) from The Globe and Mail including charting and trades.

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

Overall, the data show a significant uptick in the volume of IDR cases and corresponding administrative costs.

Moby summary of Tenon Medical, Inc.'s Q4 2025 earnings call ...

Tenon Medical, Inc. (NASDAQ:TNON) Q4 2025 Earnings Call Transcript March 19, 2026 Tenon Medical, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.36. Operator: Greetings ...

The Implications For Regulatory And IP Strategy. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...

Thursday, March 19, 2026 at 4:30 p.m. ET Chief Executive Officer — Steven Foster Chief Financial Officer — Kevin Williamson ...

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsSteven Foster - CEO, President & DirectorKevin ...

Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 ...

The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli ...